3min chapter

Talking Biotech with Dr. Kevin Folta cover image

Status of the Biotech Salmon - Silvia Wulf

Talking Biotech with Dr. Kevin Folta

CHAPTER

Why the FDA Approval Process Was So Long

There has been a lot of criticism about this, mostly social media outrage by non-experts. What were some of the most unfounded but frequent concerns that were levied by critics? And can you help our audience respond to them? Well, the criticisms originally targeted safety. It was clear to our critics that they really couldn't talk about safety because that sort of asked an answer. So labeling was a concern and then most recently, it's escape. There's no chance of escape. Even if there was, no one's ever proved harm. But the reality is we want to protect our salmon. And so we want to make sure that they are contained in that facility."

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode